Literature DB >> 15708998

Puma lentivirus is controlled in domestic cats after mucosal exposure in the absence of conventional indicators of immunity.

Julie A Terwee1, Jennifer K Yactor, Kerry S Sondgeroth, Sue Vandewoude.   

Abstract

A high percentage of free-ranging pumas (Felis concolor) are infected with feline lentiviruses (puma lentivirus, feline immunodeficiency virus Pco [FIV-Pco], referred to here as PLV) without evidence of disease. PLV establishes productive infection in domestic cats following parenteral exposure but, in contrast to domestic cat FIV, it does not cause T-cell dysregulation. Here we report that cats exposed to PLV oro-nasally became infected yet rapidly cleared peripheral blood mononuclear cell (PBMC) proviral load in the absence of a correlative specific immune response. Two groups of four specific-pathogen-free cats were exposed to PLV via the mucosal (oro-nasal) or parenteral (i.v.) route. All animals were PBMC culture positive and PCR positive within 3 weeks postinfection and seroconverted without exhibiting clinical disease; however, three or four oro-nasally infected animals cleared circulating proviral DNA within 3 months. Antibody titers reached higher levels in animals that remained persistently infected. PLV antigen-induced proliferation was slightly greater in mucosally inoculated animals, but no differences were noted in cytotoxic T-lymphocyte responses or cytokine profiles between groups. The distribution of virus was predominantly gastrointestinal as opposed to lymphoid in all animals in which virus was detected at necropsy. Possible mechanisms for viral clearance include differences in viral fitness required for crossing mucosal surfaces, a threshold dose requirement for persistence, or an undetected sterilizing host immune response. This is the first report of control of a productive feline or primate lentivirus infection in postnatally exposed, seropositive animals. Mechanisms underlying this observation will provide clues to containment of immunodeficiency disease and could prompt reexamination of vaccine-induced immunity against human immunodeficiency virus and other lentiviruses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15708998      PMCID: PMC548441          DOI: 10.1128/JVI.79.5.2797-2806.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

Review 1.  Human immunodeficiency virus and AIDS: insights from animal lentiviruses.

Authors:  R J Miller; J S Cairns; S Bridges; N Sarver
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

Review 2.  T cell dynamics in HIV-1 infection.

Authors:  Daniel C Douek; Louis J Picker; Richard A Koup
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

Review 3.  AIDS as a zoonosis: scientific and public health implications.

Authors:  B H Hahn; G M Shaw; K M De Cock; P M Sharp
Journal:  Science       Date:  2000-01-28       Impact factor: 47.728

4.  Simian immunodeficiency virus replicates to high levels in naturally infected African green monkeys without inducing immunologic or neurologic disease.

Authors:  S R Broussard; S I Staprans; R White; E M Whitehead; M B Feinberg; J S Allan
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

5.  Relationship of lymphoid lesions to disease course in mucosal feline immunodeficiency virus type C infection.

Authors:  L A Obert; E A Hoover
Journal:  Vet Pathol       Date:  2000-09       Impact factor: 2.221

6.  An improved flow cytometric assay for the determination of cytotoxic T lymphocyte activity.

Authors:  Karin Fischer; Reinhard Andreesen; Andreas Mackensen
Journal:  J Immunol Methods       Date:  2002-01-01       Impact factor: 2.303

7.  Nonpathogenic lion and puma lentiviruses impart resistance to superinfection by virulent feline immunodeficiency virus.

Authors:  Sue VandeWoude; Catherine A Hageman; Stephen J O'Brien; Edward A Hoover
Journal:  J Acquir Immune Defic Syndr       Date:  2002-01-01       Impact factor: 3.731

8.  T cells overexpressing interferon-gamma and interleukin-10 are found in both the thymus and secondary lymphoid tissues of feline immunodeficiency virus-infected cats.

Authors:  Y Liang; L C Hudson; J K Levy; J W Ritchey; W A Tompkins; M B Tompkins
Journal:  J Infect Dis       Date:  2000-02       Impact factor: 5.226

9.  Feline immunodeficiency virus infection is characterized by B7+CTLA4+ T cell apoptosis.

Authors:  Mary B Tompkins; Marta E Bull; Janet L Dow; Judith M Ball; Ellen W Collisson; Barbara J Winslow; Anagha P Phadke; Thomas W Vahlenkamp; Wayne A Tompkins
Journal:  J Infect Dis       Date:  2002-04-01       Impact factor: 5.226

10.  Quantitative real-time PCR for the measurement of feline cytokine mRNA.

Authors:  C M Leutenegger; C N Mislin; B Sigrist; M U Ehrengruber; R Hofmann-Lehmann; H Lutz
Journal:  Vet Immunol Immunopathol       Date:  1999-11-30       Impact factor: 2.046

View more
  22 in total

1.  Frequent transmission of immunodeficiency viruses among bobcats and pumas.

Authors:  S P Franklin; J L Troyer; J A Terwee; L M Lyren; W M Boyce; S P D Riley; M E Roelke; K R Crooks; S Vandewoude
Journal:  J Virol       Date:  2007-08-01       Impact factor: 5.103

2.  Prevention of immunodeficiency virus induced CD4+ T-cell depletion by prior infection with a non-pathogenic virus.

Authors:  Julie A Terwee; Jennifer K Carlson; Wendy S Sprague; Kerry S Sondgeroth; Sarah B Shropshire; Jennifer L Troyer; Sue VandeWoude
Journal:  Virology       Date:  2008-05-22       Impact factor: 3.616

3.  Accessory genes confer a high replication rate to virulent feline immunodeficiency virus.

Authors:  Ryan M Troyer; Jesse Thompson; John H Elder; Sue VandeWoude
Journal:  J Virol       Date:  2013-05-08       Impact factor: 5.103

4.  Recombination in feline lentiviral genomes during experimental cross-species infection.

Authors:  Mary Poss; Adam Idoine; Howard A Ross; Julie A Terwee; Sue VandeWoude; Allen Rodrigo
Journal:  Virology       Date:  2006-10-12       Impact factor: 3.616

Review 5.  Going wild: lessons from naturally occurring T-lymphotropic lentiviruses.

Authors:  Sue VandeWoude; Cristian Apetrei
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

6.  Feline Immunodeficiency Virus Cross-Species Transmission: Implications for Emergence of New Lentiviral Infections.

Authors:  Justin Lee; Jennifer L Malmberg; Britta A Wood; Sahaja Hladky; Ryan Troyer; Melody Roelke; Mark Cunningham; Roy McBride; Winston Vickers; Walter Boyce; Erin Boydston; Laurel Serieys; Seth Riley; Kevin Crooks; Sue VandeWoude
Journal:  J Virol       Date:  2017-02-14       Impact factor: 5.103

7.  Feline lentivirus evolution in cross-species infection reveals extensive G-to-A mutation and selection on key residues in the viral polymerase.

Authors:  Mary Poss; Howard A Ross; Sally L Painter; David C Holley; Julie A Terwee; Sue Vandewoude; Allen Rodrigo
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

8.  Variation in Intra-individual Lentiviral Evolution Rates: a Systematic Review of Human, Nonhuman Primate, and Felid Species.

Authors:  Emma Krakoff; Roderick B Gagne; Sue VandeWoude; Scott Carver
Journal:  J Virol       Date:  2019-07-30       Impact factor: 5.103

Review 9.  The molecular biology and evolution of feline immunodeficiency viruses of cougars.

Authors:  Mary Poss; Howard Ross; Allen Rodrigo; Julie Terwee; Sue Vandewoude; Roman Biek
Journal:  Vet Immunol Immunopathol       Date:  2008-01-19       Impact factor: 2.046

10.  Multivariate statistical analyses demonstrate unique host immune responses to single and dual lentiviral infection.

Authors:  Sunando Roy; Jennie Lavine; Francesca Chiaromonte; Julie Terwee; Sue VandeWoude; Ottar Bjornstad; Mary Poss
Journal:  PLoS One       Date:  2009-10-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.